ESC 365 - RELAX-AHF-2: Serelaxin in acute heart failure, Part 1.

HFA Premium Access

RELAX-AHF-2: Serelaxin in acute heart failure, Part 1.

Session: Late Breaking Trials I: Focus on acute heart failure

Topic: Acute Heart Failure

Speaker: Professor J. Teerlink (San Francisco, US)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor John R Teerlink

San Francisco Veterans Affairs Medical Centre, San Francisco (United States of America)

35 presentations

0 follower

10 more presentations in this session

Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study.

Speaker: Professor D. Hilfiker-Kleiner (Hannover, DE)

Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study - Discussion.

Safety and efficacy of low dose intracoronary insulin-like growth factor 1 to prevent heart failure following percutaneous coronary intervention for acute myocardial infarction (RESUS-AMI).

Speaker: Professor N. Caplice (Cork, IE)

Discussion: RESUS-AMI.

Relationship between baseline systolic blood pressure and long term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Speaker: Doctor G. cotter (Durham, US)

Access the full session

Late Breaking Trials I: Focus on acute heart failure

Speakers: Professor J. Teerlink, Professor D. Hilfiker-Kleiner, Professor N. Caplice, Doctor G. cotter

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources